Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
NTX-001 by Neuraptive Therapeutics for Peripheral Nerve Injury: Likelihood of Approval
NTX-001 is under clinical development by Neuraptive Therapeutics and currently in Phase II for Peripheral Nerve Injury. According to GlobalData,...